Global X Genomics & BiotechnGNOMETF
13F holders, Q2 2025 (June 30)2holders
0new positions
0sold out
$8.43avg. 13F price*
At the end of Q2 2025, 2 institutions reported holding Global X Genomics & Biotechn (GNOM) in their 13F filings, unchanged from Q1 2025. 0 opened new positions and 0 sold out. The largest holders were Raffa Wealth Management, LLC ($8K) and Pension & Wealth Management Advisors, Inc. ($2K).
- Company
- Global X Genomics & Biotechn
- CUSIP
- 37960A214
- Latest filing quarter
- Q2 2026
History
Number of 13F holders
Total Exit/New Position Q1 2025 → Q2 2025
| Institutions | Total Value | |
|---|---|---|
| New Positions | 0 | $0 |
| Exits | 0 | $0 |
Ownership 2 holders
| Raffa Wealth Management, LLC | 0.00% | No change | 1,007 | $8K |
| Pension & Wealth Management Advisors, Inc. | 0.00% | No change | 194 | $2K |
"% of holder's portfolio" is GNOM's weight in each manager's 13F, not the share of Global X Genomics & Biotechn the manager owns.